SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as investors consider its role as a defensive, high-dividend value play amidst a broader market rotation from high-flying tech stocks. The community is actively debating the significance of its upcoming planned separation into two companies and new CEO leadership, often dismissing recent analyst downgrades as deliberate market manipulation to facilitate accumulation at lower prices. Many anticipate substantial upside and a compelling dividend yield, contrasting with ongoing concerns about competitive pressures and past performance.

Decentraland

Decentraland ($MANA) is trending amid strong community buzz around a potential Apple partnership, Apple Pay integration, and upcoming VR capabilities, fueling widespread speculation about a 'metaverse return.' The community is actively discussing significant future growth for MANA and the broader NFT/blockchain gaming sector, with many expressing high price expectations, although some users remain cautious about its long-term utility. This renewed interest is further highlighted by mentions of whales potentially accumulating assets across the metaverse token landscape.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

Lynas Rare Earths is trending as strategic partnerships and substantial US government backing highlight ongoing efforts to establish a non-Chinese rare earth supply chain. Community discussion centers on Lynas's pivotal role in global independence for critical minerals, driven by increasing demand from sectors like AI and electric vehicles, with an upcoming quarterly report anticipated to provide further insight.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as discussions center on its foundational role in the UK's tokenized deposits pilot with major banks and the recent launch of its Quant Fusion multi-ledger rollup. The community is buzzing about its deep utility in bridging legacy finance with blockchain for CBDCs and Real World Assets, viewing its fixed token supply as a key long-term value driver. Despite impatience from some, many anticipate explosive growth as institutional adoption solidifies its position as a critical interoperability solution.

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Henry Schein Inc.

Henry Schein is trending due to significant strategic developments, including securing exclusive US distribution rights for Curodont and rolling out new AI-powered dental workflows, which are expected to boost its Dental business. These positive catalysts are reinforced by a major strategic investment from KKR and a recent share repurchase program. The community is actively discussing how these moves, combined with recent analyst upgrades, position Henry Schein for a potential rebound within the broader MedicalTech sector.

Scorpio Tankers, Inc. engages in the provision of marine transportation of petroleum products. It operates through the following segments: MR, LR2, Handymax, and LR1. It consists of wholly owned, finance leased, and bareboat chartered-in tankers. The company was founded by Emanuele A. Lauro on July 1, 2009 and is headquartered in Monaco.

Scorpio Tankers Inc

Scorpio Tankers (STNG) is trending strongly as ongoing geopolitical tensions, particularly in the Red Sea, continue to drive elevated product tanker rates and extended voyage distances across the sector. The community is actively discussing the company's aggressive debt reduction, consistent dividends, and perceived undervaluation, with several analysts recently raising price targets to reflect the robust market fundamentals. Insider confidence, highlighted by the President's recent purchase of call options, further contributes to the optimistic sentiment surrounding the stock.

NEOS ETF Trust - NEOS Bitcoin High Income ETF

NEOS Bitcoin High Income ETF

NEOS Bitcoin High Income ETF ($BTCI) is trending due to its attractive monthly dividend payouts and tax-efficient distributions, providing income-focused exposure to Bitcoin. The community is actively discussing its "juicy distribution" and long-term wealth building potential, while strategizing around ex-dividend dates and its performance relative to Bitcoin's price movements.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI) is gaining traction following recent exchange listings, including Bitget, and a developer update addressing selling pressure, fueling community confidence. Enthusiasts are actively discussing its potential to become the next major memecoin, drawing comparisons to $PEPE, and anticipating further Tier 1 exchange listings as part of its ambitious growth strategy.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is experiencing a surge in community interest, driven by reports of rapid market cap expansion and growing holder numbers, with many anticipating an imminent price rally. Discussions are focused on acquisition methods and platform availability, as users navigate varying price displays and seek clarity on its long-term potential.

Ethereum Classic

Ethereum Classic (ETC) is trending with significant community discussion, as many anticipate a major surge for the 'classic' Proof-of-Work altcoin amid broader market optimism driven by upcoming regulatory clarity and increased liquidity. Despite some frustration over its relative performance, enthusiasts are actively accumulating, viewing current price levels as a prime buying opportunity before an expected breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 27.8% in December

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totaling 404,777 shares...

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of "Hold" by Analysts

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the stock, MarketBeat.com reports. Two...

FY2025 EPS Estimate for Sutro Biopharma Increased by Analyst

Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Investment analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Sutro Biopharma in a report issued on Monday...

Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 85.9% in December

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling...

HC Wainwright Forecasts Strong Price Appreciation for Sutro Biopharma (NASDAQ:STRO) Stock

HC Wainwright increased their target price on shares of Sutro Biopharma from $2.00 to $10.00 and gave the stock a "neutral" rating in a research report on Monday...

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines PR Newswire...

Velan Capital Investment Management LP Acquires 2,030,000 Shares of Sutro Biopharma, Inc. $STRO

Velan Capital Investment Management LP lifted its stake in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 197.1% during the second quarter, according to the company in its most recent 13F...

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Hold" from Brokerages

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) have received a consensus recommendation of "Hold" from the eight research firms that are currently covering the stock, MarketBeat...

Sutro Biopharma (NASDAQ:STRO) Shares Gap Down - What's Next?

Sutro Biopharma (NASDAQ:STRO) Shares Gap Down - Time to Sell...

Sutro Biopharma (NASDAQ:STRO) Shares Gap Up - What's Next?

Sutro Biopharma (NASDAQ:STRO) Shares Gap Up - Time to Buy...

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Current Price	$13.85
Prev Close	$13.07
Open	$13.01
Dividend Yield	0.00%
50-Day Moving Average	$9.85
Beta	1.50
Avg. Volume	129,482.50
PE Ratio	-0.53

52-Week High	$21.50
52-Week Low	$5.23
Market Capitalization	$117.74M
EPS (Annual)	-$29.61
Price to Book	-1.35
Revenue Per Employee	$183,559.17
Enterprise Value/EBITDA	N/A

STRO
Sutro Biopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STRO News

STROSutro Biopharma Inc